alk3 peptide ALK-3 - THR-123peptide ALK3 / BMPR1A Antibody Blocking Peptide Exploring the alk3 peptide: A Key Player in Cellular Signaling and Therapeutic Potential

THR-123peptide The alk3 peptide is emerging as a significant molecule in biological research, particularly in understanding cellular signaling pathways and exploring therapeutic applications. This peptide is intrinsically linked to Activin-like kinase 3 (ALK3), also known as Bone Morphogenetic Protein Receptor Type 1A (BMPR1A). BMPR1A is a crucial transmembrane serine/threonine kinase belonging to the TGF beta receptor superfamily. Its role is integral to various biological processes, including development, regeneration, and disease modulation.

ALK3 acts as a receptor for bone morphogenetic proteins (BMPs), a group of signaling molecules that play vital roles in a multitude of cellular functionsBased on these observations, we conclude that BMP signaling is upregulated in NRCs in response to hypertrophic stimuli. ALK2 andALK3appear to be the BMP type .... The interaction of BMPs with ALK3 initiates downstream signaling cascades, often involving the phosphorylation of intracellular SMADs, which then regulate gene expression. This intricate process highlights the importance of ALK3 in maintaining cellular homeostasis.

Research has demonstrated that ALK3 is not just a passive receptor but actively participates in complex biological events. For instance, studies indicate that ALK3 is elevated early in diseased kidneys after injury, suggesting its involvement in the progression of renal pathology. Conversely, ALK3 functions to inhibit fibrosis by controlling inflammation, apoptosis, and the induction of an epithelium-to-mesenchymal transition (EMT). This dual role underscores the therapeutic potential of targeting the alk3 peptide pathway.

One of the most exciting areas of research involves the development of alk3 peptide agonists. THR-123 has garnered significant attention as an orally active ALK3 peptide agonistALK3 Inhibitor, Agonist, Gene. This peptide exhibits a relatively weak binding affinity for ALK2 but does not bind to ALK6, indicating a degree of specificityHuman BMPR1A (ALK3), GST Tag Recombinant Protein. THR-123 has shown promise in suppressing inflammation and has been investigated for its ability to promote pancreatic β-cell regeneration in situ.Anti-fibrotic peptides and their use in methods for treating ... Studies have reported the formation of new β-cells in diabetic mice treated with THR-123, offering a potential avenue for treating diabetes. Furthermore, THR-123 is described as a cyclic peptide with BMP-7-like activity, reinforcing its role as a BMP-7 mimetic that can reverse established renal disease progression and facilitate kidney regeneration.

Beyond agonists, the understanding of alk3 peptide also extends to its role in maintaining cellular properties.Recombinant Human BMPRIA/ALK-3 Protein (Fc & His Tag) It has been observed that ALK3 maintains cell stemness by inhibiting Wnt signalingHuman BMPR1A (ALK3), GST Tag Recombinant Protein. This finding is particularly relevant in the context of regenerative medicine and cancer biology.

The alk3 peptide is also utilized in various research tools. ALK3 / BMPR1A Antibody Blocking Peptides, such as LS-E6794 and LS-E4217, are employed for pre-absorption and neutralization of antibody binding sites, ensuring the specificity of experimental results. These blocking peptides are derived from the immunizing peptide sequence used to generate specific antibodies against ALK3THR-123, is a novel orally availableAlk-3 receptor peptide agonistand BMP-7 mimetic. THR-123 inhibited renal disease progression and reversed established .... Furthermore, Alk3 Recombinant Protein is available for research purposes, allowing scientists to study its biochemical properties and interactions in vitro.Recombinant protein encompassing a sequence within the center region of human BMPR-IA/ALK-3. The exact sequence is proprietary. Localization. Membrane.

The involvement of ALK3 in various pathological conditions, including juvenile polyposis syndrome, Cowden's disease, and kidney injury, highlights its significance in human health. The gene encoding BMPR1A is also implicated as a minor susceptibility gene for PTEN-mutation-negative conditions.

In the realm of drug development, ALK3 Inhibitors are also being explored. Compounds like LDN-193189 are selective BMP signaling inhibitors that can inhibit ALK1, ALK2, ALK3, and ALK6 with low IC50 values.Product Description. BMPR1A (also known as bone morphogenetic protein receptor 1A) is a member of the transmembrane serine/threonine kinase family that includes the type I receptors BMPR1A and BMPR1B, and the type II receptor BMPR2. BMPR1A acts as a minor susceptibility gene for PTEN-mutation-negative. Such inhibitors could be valuable for conditions where ALK3-mediated signaling is detrimental.

The diverse applications and inherent biological significance of the alk3 peptide and its associated receptor ALK3 (BMPR1A) continue to drive research. From understanding fundamental cellular processes to developing novel therapeutic strategies for conditions like kidney fibrosis and diabetes, the alk3 peptide remains a focal point of scientific inquiryALK3 Inhibitors | Selleckchem.com. The ability to specifically target ALK3 with peptides like THR-123 offers promising avenues for future medical advancements.Pancreatic β-cell regeneration in situ by the ALK3 agonist ... Researchers are also investigating the presence of P2RY1+/ALK3bright+ cells within specific tissues, further expanding our knowledge of ALK3 expression patterns and functional roles.作者：SJ Allison·2012·被引用次数：2—A peptide agonist that targets the bone morphogenic protein (BMP) 7 receptor,Alk3, reverses fibrosis and facilitates kidney regeneration in ... The development of antibodies like Human BMPR-IA/ALK-3 Antibody and associated reagents further aids in the investigation of this critical signaling pathway.作者：P Marañón·2024·被引用次数：8—This study shows the protective effect ofALK3receptor inhibition against APAP-induced hepatotoxicity. The precise mechanism by which ALK3 mediates its effects, including its interaction with other signaling pathways like Wnt signaling, is a subject of ongoing investigation. The availability of ALK3 Recombinant Protein and BMPR1A Gene information provides essential resources for this research.